These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1122549)

  • 1. Oral oxamniquine in the treatment of persistent Schistosoma mansoni bilharziasis.
    Blair DM; Weber MC
    Cent Afr J Med; 1975 Feb; 21(2):24-6. PubMed ID: 1122549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of schistosomiasis mansoni using oral oxamniquine].
    Domingues AL; Coutinho A
    Rev Inst Med Trop Sao Paulo; 1975; 17(3):164-80. PubMed ID: 1135569
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials with oxamniquine, by oral route, in schistosomiasis mansoni.
    Katz N; Grinbaum E; Chaves A; Zicker F; Pellegrino J
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):371-7. PubMed ID: 794980
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of oxamniquine in Schistosoma mansoni bilharziasis in Madagascar in a hospital milieu].
    Queinnec J; Moyroud J
    Arch Inst Pasteur Madagascar; 1981; 48(1):143-9. PubMed ID: 7342891
    [No Abstract]   [Full Text] [Related]  

  • 5. Field experiences with oral oxamniquine in the treatment of schistosomiasis mansoni.
    Coura JR; Argento CA; Conceição MJ; Lewis EM; dos Santos ML; Magalhães P
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):77-84, 195-202. PubMed ID: 7455514
    [No Abstract]   [Full Text] [Related]  

  • 6. Schistosoma mansoni treatment with oral oxamniquine in Zambia.
    Gupta KK
    East Afr Med J; 1984 Aug; 61(8):641-4. PubMed ID: 6399028
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic-protective activity of oral oxamniquine against Schistosoma mansoni infection in hamsters.
    Girgis NI; Mansour NS; Kahlil SB
    East Afr Med J; 1979 Sep; 56(9):428-30. PubMed ID: 520260
    [No Abstract]   [Full Text] [Related]  

  • 8. Field use of oral oxamniquine in the treatment of S. mansoni.
    Eyakuze VM; Rutasitara WK; Ndalahwa JB
    East Afr Med J; 1979 Jan; 56(1):22-5. PubMed ID: 436702
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose.
    da Silva LC; Sette Júnior H; Christo C; Sette PC; Kaye B
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):58-64, 175-81. PubMed ID: 7455511
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxamniquine (Vansil) in the treatment of Schistosoma mansoni infections in Rhodesia.
    de V Clarke V
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):20-3. PubMed ID: 606374
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxamniquine (Vansil) in the treatment of schistosomiasis in Rhodesia.
    de Clarke V
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):28-31, 144-7. PubMed ID: 7455506
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary clinical trial of oral oxamniquine in the treatment of Schistosoma mansoni in Ethiopia.
    Ayele T
    East Afr Med J; 1984 Aug; 61(8):632-6. PubMed ID: 6399027
    [No Abstract]   [Full Text] [Related]  

  • 14. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose-finding trials of oral oxamniquine in Rhodesia.
    de V Clarke V; Blair DM; Weber MC; Garnett PA
    S Afr Med J; 1976 Oct; 50(46):1867-71. PubMed ID: 996687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice.
    Amin AM; Mikhail EG
    J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical development of oxamniquine in Egypt.
    Saif M; Gaber A
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):18-27, 134-43. PubMed ID: 7455504
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-ranging clinical trial with oltipraz in schistosomiasis mansoni.
    Katz N; Rocha RS; Chaves A
    Rev Inst Med Trop Sao Paulo; 1982; 24(1):40-8. PubMed ID: 6750759
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of schistosomiasis mansoni with Oxamniquine; present status of our observations].
    Pedro RJ; Amato Neto V; Rodrigues MS; Magalhães LA; Lucca RS
    Rev Inst Med Trop Sao Paulo; 1977; 19(2):130-7. PubMed ID: 897480
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of bilharziasis due to Schistosoma haematobium infection.
    Blair DM
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):23-5. PubMed ID: 606375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.